Publication | Closed Access

45 Continued virologic and biochemical improvement through 96 weeks of entecavir treatment in HBeAg(−) chronic hepatitis B patients (study ETV-027)

Hepatic DisordersHepatologyContinued VirologicViral HepatitisEntecavir TreatmentHepatitis BHepatitisVirologyAntiviral TherapyLiver DiseaseChronic Viral InfectionBiochemical ImprovementMedicine